“Pathology confirms invasive ductal carcinoma.”

I had said those words to patients many times before. This time, they were said to me. For years, I had been the voice on the other end of that call, gently guiding patients through one of the hardest moments of their lives. I knew how to say the words. I knew how to explain the diagnosis. I knew how to help women process what came next.

But that day, I was not the physician. I was the patient.

I was on call, anxiously waiting for the final pathology report. When the diagnosis came, time seemed to pause. I remember feeling stunned and confused, as if my mind suddenly refused to process what I was hearing. Years of medical training vanished in an instant. Nothing made sense. It felt almost like an out-of-body experience, as if I were watching someone else’s life unfold. No amount of textbooks, clinical guidelines, or surgical experience could have prepared me for that moment.

And suddenly, I understood my patients in a way I never had before. My physician hat fell off, and I was simply a woman, a mother. Even though part of my brain understood what the next steps in management would be, another part of me was overwhelmed by a single terrifying thought: What if my boys grow up without their mother?

The masking effect of dense breast tissue

That quiet fear lives in the minds of many women who hear those same words. I was fortunate. My cancer was detected early. But many women are not as lucky. As an obstetrician-gynecologist, my role is to guide women through the different stages of their lives. I counsel them on preventive care, how to lower cholesterol and blood pressure, reduce cardiovascular risk, and identify factors that increase the likelihood of certain cancers so we can develop strategies to protect their health.

And like many physicians, I followed those recommendations myself. I kept up with my screenings. We often say that mammography saves lives through early detection. But the words screening and prevention have taken on a deeper meaning for me now.

Like many women, I was reassured that my mammogram was normal. The report did mention that my breasts were heterogeneously dense, but at the time that detail did not seem significant. It was not until 2024 that the U.S. Food and Drug Administration required radiologists to include breast density information in mammography reports provided directly to patients.

Breast density is categorized into four groups:

• A: almost entirely fatty
• B: scattered fibroglandular density
• C: heterogeneously dense
• D: extremely dense

Why does this matter? Because the denser the breast tissue, the more difficult it becomes for mammography to detect cancer. Dense tissue can mask tumors, hiding them beneath layers of fibroglandular tissue. That is exactly what happened to me. My cancer was hidden within that dense tissue.

Clinical implications of dense breasts

Dense breasts have two important clinical implications. First, they reduce the sensitivity of mammography. In women with extremely dense breasts, mammography may detect cancer only about 50 percent of the time, essentially the odds of flipping a coin. Second, dense breast tissue itself is an independent risk factor for developing breast cancer.

As physicians, we constantly strive to stay current with evolving guidelines so we can provide the best care for our patients. When I realized that women with the densest breasts have a four- to six-fold increased relative risk of breast cancer compared with women with fatty breasts, I began asking an important question: What else can we do?

As I explored the literature further, it became clear that many women with dense breasts may benefit from additional imaging, such as ultrasound or MRI, to improve cancer detection. In medicine, we know that early detection changes outcomes.

Navigating supplemental screening guidelines

The 2025 NCCN guidelines now recognize dense breast tissue as an increased-risk category that may warrant enhanced screening strategies.

For women with heterogeneously dense breasts (Category C):

• Annual screening mammogram with tomosynthesis beginning no later than age 40
• Clinical encounter every six to 12 months
• Consider supplemental screening through shared decision-making

For women with extremely dense breasts (Category D):

• Annual screening mammogram with tomosynthesis beginning no later than age 40
• Breast MRI with and without contrast beginning at age 50 (with consideration starting at age 40)
• Alternative options if MRI is not available include contrast-enhanced mammography (CEM), molecular breast imaging (MBI), or whole-breast ultrasound
• Clinical encounter every six to 12 months

Screening decisions should always be individualized, taking into account a woman’s overall risk profile. At this time, the American College of Obstetricians and Gynecologists (ACOG) does not recommend routine supplemental imaging in asymptomatic women with dense breasts who have no additional risk factors.

Advocating for early detection and shared decision-making

In my case, I had followed every screening recommendation exactly as advised. But as new research emerged, I began to recognize that my dense breast tissue could potentially hide small lesions. So I underwent a screening MRI.

And there it was.

My cancer appeared clearly on the images, bright and unmistakable. You did not need to be a radiologist to see that the mass did not belong. I was fortunate. My cancer was detected early, and I was able to receive timely treatment. But my story could have been very different. And for many women, it is.

Women deserve to understand their individual risk factors, including breast density, and how those factors may influence their screening options. Conversations about breast density should not end with a line in a radiology report, they should begin there. Education, access to screening, and shared decision-making between patients and physicians are essential if we want to detect cancer earlier and improve outcomes.

Because early detection does more than treat cancer. It preserves lives, families, and futures.

As physicians, we dedicate our careers to protecting the health of our patients. As patients, we realize how deeply those protections matter. Now I carry both perspectives with me. And that is why I will continue to advocate for women to have the knowledge, screening, and access they need, so that more mothers get the chance to watch their children grow up.

Amantia Kennedy is an obstetrician-gynecologist.